Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology

Abstract Background Chimeric antigen receptor T (CAR-T) cell therapy, as an emerging anti-tumor treatment, has garnered extensive attention in the study of targeted therapy of multiple tumor-associated antigens in hepatocellular carcinoma (HCC). However, the suppressive microenvironment and individu...

全面介绍

书目详细资料

Principais autores:	Keming Lin, Baijin Xia, Xuemei Wang, Xin He, Mo Zhou, Yingtong Lin, Yidan Qiao, Rong Li, Qier Chen, Yuzhuang Li, Jinzhu Feng, Tao Chen, Cancan Chen, Xinyu Li, Hui Zhang, Lijuan Lu, Bingfeng Liu, Xu Zhang
格式:	Artigo
语言:	Inglês
出版:	BMC 2024-04-01
丛编:	Journal of Translational Medicine
主题:	HCC Nanoparticle Nanobody Phage display Nb-derived CAR-T cell therapy
在线阅读:	https://doi.org/10.1186/s12967-024-05159-x
标签:	添加标签 没有标签, 成为第一个标记此记录!